Amid growing public anger over the perceived hoarding of excess vaccine supplies by richer nations and rising calls from South Africa and India to waive the intellectual property (IP) rights to the vaccines to improve global supplies, the Biden Administration finally said "yes."
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?